Bavarian Nordic A/S (BVNKF)
OTCMKTS · Delayed Price · Currency is USD
30.51
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of $2.31 billion as of February 12, 2026. Its market cap has increased by 5.04% in one year.
Market Cap
2.31B
Enterprise Value
1.85B
Revenue
1.08B
Ranking
n/a
PE Ratio
6.00
Stock Price
$30.51
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 6.78M to 2.31B, an increase of 33,900.15%. That is a compound annual growth rate of 23.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.31B | -1.97% |
| Dec 30, 2025 | 2.35B | 13.64% |
| Dec 30, 2024 | 2.07B | 0.95% |
| Dec 29, 2023 | 2.05B | -5.24% |
| Dec 30, 2022 | 2.16B | -24.82% |
| Dec 30, 2021 | 2.88B | 59.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 141.56M |
| HST Global | 139.70M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |